新辅助化疗联合肺癌根治术在肺癌治疗中的应用效果

The Effect of Neoadjuvant Chemotherapy Combined With Radical Resection of Lung Cancer in the Treatment of Lung Cancer

目的探讨新辅助化疗联合肺癌根治术在肺癌治疗中的应用效果。方法选取我院收治的肺癌患者82例作为研究对象。将入选的患者随机分为对照组与研究组,每组各41例。对照组患者直接采用肺癌根治术治疗,研究组患者采用新辅助化疗联合肺癌根治术治疗。结果研究组及对照组患者缓解率分别为80.49%、31.71%,两组比较,差异具有统计学意义(P<0.05)。研究组患者术后并发症发生率低于对照组,差异具有统计学意义(P<0.05)。结论新辅助化疗联合肺癌根治术可有效减少并发症,疗效安全可靠,在肺癌的治疗中具有重要的临床意义。

Objective To evaluate the effect of neoadjuvant chemotherapy combined with radical resection of lung cancer in the treatment of lung cancer. Methods 82 cases of lung cancer patients in our hospital were selected as the research object. The selected patients were randomly divided into the control group and the study group, 41 cases in each group. Patients in the control group were treated with radical resection of lung cancer, patients in the study group were treated with neoadjuvant chemotherapy combined with radical resection of lung cancer. Results The remission rates of the study group and the control group were 80.49% and 31.71% respectively, and the difference between the two groups was statistically significant （P 〈 0.05）. The incidence of postoperative complications in the study group was lower than that in the control group, and the difference was statistically significant （P 〈 0.05）. Conclusion Neoadjuvant chemotherapy combined with radical resection of lung cancer can effectively reduce complications, and the efficacy is safe and reliable. It has important clinical significance in the treatment of lung cancer.